LONDON, March 31, 2025 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding round. The financing ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says ...

Drug design and development is expensive, often insufficient, and laced with the tendency for failure. Traditionally, it’s a hit-and-miss process that can stretch over a decade and consume around $2.3 ...

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences’ (UB SPPS) Drug Discovery, Development and Evaluation (DDDE) Hub, a leading research engine in the fields of pharmaceutical ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and ...

The most familiar artificial intelligence (AI) applications include text generation, facial recognition, and autonomous driving. But there are other AI applications that deserve their share of ...

The leading scientific social networking website and producer of educational virtual events and webinars.

Morphogens are the secreted molecules that pattern embryonic tissues. These molecules are important not only for the embryo during development, but also for the adult during tissue repair. However, ...